Premier (NASDAQ:PINC - Get Free Report) is expected to be announcing its Q4 2025 earnings results before the market opens on Tuesday, August 19th. Analysts expect the company to announce earnings of $0.34 per share and revenue of $247.10 million for the quarter.
Premier Stock Up 1.9%
Shares of NASDAQ PINC traded up $0.47 during trading on Friday, hitting $25.10. 918,697 shares of the company traded hands, compared to its average volume of 1,583,445. Premier has a 1 year low of $17.23 and a 1 year high of $25.27. The company has a 50-day moving average price of $21.99 and a 200-day moving average price of $20.77. The firm has a market capitalization of $2.07 billion, a P/E ratio of 44.03 and a beta of 0.56.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on PINC shares. Piper Sandler boosted their price objective on shares of Premier from $19.00 to $24.00 and gave the company a "neutral" rating in a research note on Wednesday, May 21st. Robert W. Baird boosted their price objective on shares of Premier from $19.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. Finally, Canaccord Genuity Group boosted their price objective on shares of Premier from $19.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, May 8th. Seven equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, Premier has an average rating of "Hold" and an average target price of $22.20.
Check Out Our Latest Research Report on PINC
Insider Buying and Selling at Premier
In other Premier news, Director Helen M. Boudreau sold 2,000 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $22.88, for a total value of $45,760.00. Following the transaction, the director owned 18,668 shares in the company, valued at $427,123.84. The trade was a 9.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John T. Bigalke sold 1,137 shares of the business's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $23.03, for a total transaction of $26,185.11. Following the completion of the transaction, the director owned 28,673 shares in the company, valued at $660,339.19. This represents a 3.81% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.
Institutional Investors Weigh In On Premier
Institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its stake in shares of Premier by 316.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,968 shares of the company's stock valued at $65,000 after purchasing an additional 2,255 shares in the last quarter. M&T Bank Corp acquired a new stake in shares of Premier in the 2nd quarter valued at about $204,000. WINTON GROUP Ltd acquired a new stake in shares of Premier in the 2nd quarter valued at about $248,000. Russell Investments Group Ltd. raised its stake in shares of Premier by 3.2% in the 2nd quarter. Russell Investments Group Ltd. now owns 27,868 shares of the company's stock valued at $611,000 after purchasing an additional 852 shares in the last quarter. Finally, Brevan Howard Capital Management LP raised its stake in shares of Premier by 223.7% in the 2nd quarter. Brevan Howard Capital Management LP now owns 34,957 shares of the company's stock valued at $767,000 after purchasing an additional 24,157 shares in the last quarter. Institutional investors and hedge funds own 74.41% of the company's stock.
Premier Company Profile
(
Get Free Report)
Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.
See Also

Before you consider Premier, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Premier wasn't on the list.
While Premier currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.